Barinthus Biotherapeutics
BRNS
#10495
Rank
$24.51 M
Marketcap
$0.60
Share price
-0.99%
Change (1 day)
-66.85%
Change (1 year)

Revenue for Barinthus Biotherapeutics (BRNS)

Revenue in 2026 (TTM): N/A

In 2025 the company made a revenue of N/A a decrease over the revenue in the year 2024 that were of $14.96 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Barinthus Biotherapeutics from 2020 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) N/A
2025 N/A-100%
2024 $14.96 M1766.46%
2023 $0.8 M-98.21%
2022 $44.7 M16580.22%
2021 $0.26 M-94.44%
2020 $4.82 M